Synopsis The proportion of unexpected sarcoma at the time of hysterectomy for presumed benign indication remains unclear. Thus, the present study aimed to estimate the incidence of sarcoma among women undergoing hysterectomy for benign indication. This week’s “MED FACT” discusses a clinical trial from American Journal of Obstetrics and Gynecology, “Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study”. Authors: Francesco Multinu et. al.
Key Takeaways Unexpected uterine sarcoma was low in all women undergoing hysterectomy for benign indication. Objective: To estimate the incidence of sarcoma among women undergoing hysterectomy for benign indication. Study Type: Population-based study Participants: 4,232 What Was The Need For This Study? Minimally invasive hysterectomy may require the use of morcellation to remove the uterus. In the…
